U.S. panel backs approval of Sanofi combination diabetes drug

May 25 (Reuters) - One day after recommending approval of a

new diabetes drug made by Novo Nordisk A/S, a U.S.

advisory panel on Wednesday recommended approval of a similar

product made by Sanofi SA.

Read more